Department of Obstetrics, Gynecology, and Reproductive Medicine, Icahn School of Medicine at Mount Sinai Hospital, New York, New York.
Obstet Gynecol. 2020 Aug;136(2):283-287. doi: 10.1097/AOG.0000000000003985.
To evaluate the rate of coronavirus disease 2019 (COVID-19) infection with the use of universal testing in our obstetric population presenting for scheduled deliveries, as well as the concordance or discordance rate among their support persons during the initial 2-week period of testing. Additionally, we assessed the utility of a screening tool in predicting severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) testing results in our cohort.
This was an observational study in which all women who were scheduled for a planned delivery within the Mount Sinai Health system from April 4 to April 15, 2020, were contacted and provided with an appointment for themselves as well as their support persons to undergo COVID-19 testing 1 day before their scheduled delivery. Both the patients and the support persons were administered a standardized screen specific for COVID-19 infection by telephone interview. Those support persons who screened positive were not permitted to attend the birth. All patients and screen-negative support persons underwent SARS-CoV-2 testing.
During the study period, 155 patients and 146 support persons underwent SARS-CoV-2 testing. The prevalence of asymptomatic COVID-19 infection was 15.5% (CI 9.8-21.2%) and 9.6% (CI 4.8-14.4%) among patients and support persons, respectively. The rate of discordance among tested pairs was 7.5%. Among patients with COVID-19 infection, 58% of their support persons also had infection; in patients without infection, fewer than 3.0% of their support persons had infection.
We found that more than 15% of asymptomatic maternity patients tested positive for SARS-CoV-2 infection despite having screened negative with the use of a telephone screening tool. Additionally, 58% of their asymptomatic, screen-negative support persons also tested positive for SARS-CoV-2 infection. Alternatively, testing of the support persons of women who had tested negative for COVID-19 infection had a low yield for positive results. This has important implications for obstetric and newborn care practices as well as for health care professionals.
评估在我们的产科人群中,使用通用检测方法对接受计划性分娩的孕妇进行 2019 年冠状病毒病(COVID-19)感染率,以及在最初的 2 周检测期间,其支持人员之间的一致性或不一致率。此外,我们评估了在我们的队列中,一种筛查工具在预测严重急性呼吸系统综合征冠状病毒 2(SARS-CoV-2)检测结果方面的效用。
这是一项观察性研究,其中 2020 年 4 月 4 日至 4 月 15 日期间,所有在西奈山健康系统接受计划性分娩的女性都接到了通知,并为她们自己及其支持人员预约了在预定分娩前一天进行 COVID-19 检测。患者和支持人员都通过电话访谈接受了 COVID-19 感染的标准化筛查。那些筛查阳性的支持人员不允许参加分娩。所有患者和筛查阴性的支持人员都接受了 SARS-CoV-2 检测。
在研究期间,有 155 名患者和 146 名支持人员接受了 SARS-CoV-2 检测。无症状 COVID-19 感染的患病率分别为患者和支持人员的 15.5%(95%CI 9.8-21.2%)和 9.6%(95%CI 4.8-14.4%)。经过检测的配对之间的不一致率为 7.5%。在 COVID-19 感染患者中,其 58%的支持人员也有感染;在无感染的患者中,其不到 3.0%的支持人员有感染。
我们发现,尽管使用电话筛查工具筛查为阴性,但仍有 15%以上的无症状产妇患者 SARS-CoV-2 感染检测呈阳性。此外,他们的 58%无症状、筛查阴性的支持人员也检测出 SARS-CoV-2 感染呈阳性。相反,对 COVID-19 检测呈阴性的女性的支持人员进行检测,其阳性结果的检出率较低。这对产科和新生儿护理实践以及卫生保健专业人员具有重要意义。